Reaction Details Report a problem with these data
Target
IgG receptor FcRn large subunit p51
Ligand
BDBM50270890
Substrate
n/a
Meas. Tech.
ChEMBL_552585 (CHEMBL956457)
pH
6±n/a
Kd
3300±n/a nM
Comments
extracted
Citation
 Mezo, AR; McDonnell, KA; Castro, A; Fraley, C Structure-activity relationships of a peptide inhibitor of the human FcRn:human IgG interaction. Bioorg Med Chem 16:6394-405 (2008) [PubMed]  Article 
Target
Name:
IgG receptor FcRn large subunit p51
Synonyms:
FCGRN_HUMAN | FCGRT | FCRN
Type:
PROTEIN
Mol. Mass.:
39742.86
Organism:
Homo sapiens (Human)
Description:
ChEMBL_627631
Residue:
365
Sequence:
MGVPRPQPWALGLLLFLLPGSLGAESHLSLLYHLTAVSSPAPGTPAFWVSGWLGPQQYLSYNSLRGEAEPCGAWVWENQVSWYWEKETTDLRIKEKLFLEAFKALGGKGPYTLQGLLGCELGPDNTSVPTAKFALNGEEFMNFDLKQGTWGGDWPEALAISQRWQQQDKAANKELTFLLFSCPHRLREHLERGRGNLEWKEPPSMRLKARPSSPGFSVLTCSAFSFYPPELQLRFLRNGLAAGTGQGDFGPNSDGSFHASSSLTVKSGDEHHYCCIVQHAGLAQPLRVELESPAKSSVLVVGIVIGVLLLTAAAVGGALLWRRMRSGLPAPWISLRGDDTGVLLPTPGEAQDADLKDVNVIPATA
  
Inhibitor
Name:
BDBM50270890
Synonyms:
CHEMBL524691
Type:
Small organic molecule
Emp. Form.:
C90H128N24O22S2
Mol. Mass.:
1962.257
SMILES:
CC(C)C[C@H](NC(=O)[C@H]1CCCN1C(=O)[C@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O |r,wU:77.82,55.67,47.51,88.94,33.43,4.4,94.98,109.116,119.125,134.142,wD:66.78,51.55,22.32,15.15,8.7,113.119,(35.81,-36.5,;34.3,-36.78,;33.78,-38.23,;33.3,-35.61,;31.79,-35.88,;30.79,-34.71,;31.31,-33.26,;32.82,-32.98,;30.3,-32.08,;31.44,-31.05,;30.82,-29.65,;29.3,-29.82,;28.98,-31.31,;27.64,-32.08,;27.64,-33.62,;26.3,-31.32,;25.99,-29.82,;24.47,-29.66,;23.84,-31.05,;24.97,-32.08,;23.64,-31.31,;23.64,-29.77,;22.31,-32.08,;22.31,-33.62,;23.64,-34.39,;24.96,-33.63,;26.3,-34.39,;26.3,-35.93,;24.98,-36.71,;23.64,-35.94,;20.98,-31.31,;19.64,-32.08,;19.64,-33.62,;18.31,-31.31,;18.31,-29.77,;19.64,-29,;21.06,-29.63,;22.08,-28.48,;21.3,-27.16,;19.8,-27.49,;16.97,-32.08,;15.64,-31.31,;15.64,-29.77,;14.31,-32.08,;12.97,-31.31,;11.64,-32.08,;11.64,-33.62,;10.31,-31.31,;8.97,-32.08,;7.64,-31.31,;7.64,-29.77,;6.31,-32.08,;4.97,-31.31,;3.63,-32.08,;3.63,-33.62,;2.31,-31.31,;2.31,-29.77,;3.63,-29,;4.98,-29.77,;6.3,-29,;6.3,-27.47,;4.97,-26.71,;3.63,-27.48,;.97,-32.08,;-.37,-31.31,;-.37,-29.77,;-1.69,-32.08,;-1.69,-33.62,;-.37,-34.39,;-.37,-35.93,;.97,-36.7,;.97,-38.24,;-.37,-39.01,;2.31,-39.01,;-3.03,-31.31,;-4.37,-32.08,;-4.37,-33.62,;-5.7,-31.31,;-7.03,-32.08,;-5.7,-29.77,;-4.37,-29,;-4.37,-27.46,;-5.7,-26.69,;-3.03,-26.69,;6.31,-33.62,;7.85,-33.62,;4.77,-33.62,;6.31,-35.16,;10.31,-29.77,;8.97,-29,;11.64,-29,;31.27,-37.33,;29.75,-37.61,;32.26,-38.51,;31.75,-39.96,;32.74,-41.13,;34.26,-40.85,;34.78,-39.42,;36.28,-39.13,;37.28,-40.3,;38.8,-40.02,;36.77,-41.75,;35.26,-42.03,;30.23,-40.24,;29.23,-39.06,;29.71,-41.68,;30.52,-43.13,;29.39,-44.38,;27.86,-43.69,;28.28,-42.2,;27.15,-41.15,;27.48,-39.65,;25.68,-41.61,;24.55,-40.57,;24.89,-39.07,;23.75,-38.02,;23.07,-41.02,;22.74,-42.52,;21.94,-39.98,;20.48,-40.44,;20.14,-41.94,;18.67,-42.4,;17.53,-41.35,;18.33,-43.9,;19.34,-39.39,;19.68,-37.89,;17.87,-39.85,;16.74,-38.81,;15.27,-39.26,;14.93,-40.76,;14.14,-38.22,;12.47,-38.41,;11.76,-36.9,;12.98,-35.75,;14.2,-36.71,;15.59,-36.07,;15.72,-34.54,;16.86,-36.95,)|
Structure:
Search PDB for entries with ligand similarity: